OMI

Owens & Minor Appoints Jonathan Leon as CFO

Owens & Minor, Inc. (NYSE: OMI) has announced the appointment of Jonathan Leon as the Executive Vice President and Chief Financial Officer, effective immediately. Leon, who has been with the company since 2017, previously served as the interim Chief Financial Officer and Corporate Treasurer since June 2024. He brings more than 25 years of corporate finance, treasury, and strategy experience to the role, having also served as Senior Vice President and Corporate Treasurer at the company, leading its financial operations since 2017.

Before joining Owens & Minor, Mr. Leon spent 18 years at The Brink's Company, where he served as Treasurer and in several related investor relations and corporate finance roles. Mr. Leon earned a B.S. in finance from the University of Connecticut.

Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. The company and its affiliated brands, Apria®, Byram®, and Halyard*, have been in operation for over 100 years, with a workforce of more than 20,000 teammates worldwide.

The announcement comes as the company continues its progress toward achieving its long-term goals outlined at its recent Investor Day. The appointment of Jonathan Leon as the Chief Financial Officer is expected to contribute to the company's financial acumen and leadership capabilities, further supporting its commitment to delivering comfort and confidence behind the scenes so healthcare stays at the forefront. Following these announcements, the company's shares moved -1.0%, and are now trading at a price of $15.88. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS